Delivery Order SPE2DB24D1205-SPE2DB25FCUDQ
Award Date
2/20/25
Potential Completion Date
3/13/25
Potential Value
$9.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,655.40 firm fixed-price delivery order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The $9,025.76 Firm Fixed Price contract is for the supply of 4,565,122,173 units of the drug ZEPZELCA 4 MG VIALS. This award is part of a larger Indefinite Delivery Contract between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,675.40 Firm Fixed Price Delivery Order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty cancer medication. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, valued at $9,025.76, for the delivery of the pharmaceutical product ZEPZELCA 4 MG VIALS. The award was made by the Defense Logistics Agency (DLA), a defense agency, on July 29, 2024, with an ultimate completion date of August 19, 2024. The contract is a delivery order with a firm fixed price. There is no set-aside designation mentioned. This award appears to be associated with a larger Indefinite...
This federal contract award to Amerisourcebergen Drug Corp (DUNS: TGxsdkVQRGhOYUpNR001SFhYRURNdz09) was issued by the Defense Logistics Agency (DLA) for the delivery of Zepzelca 4 mg vials, a specialty pharmaceutical product. The $35,563.44 firm fixed-price delivery order has an ultimate completion date of August 21, 2023 and was awarded on July 31, 2023. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $9,025.76 firm fixed price delivery order is for the supply of 4 mg vials of the cancer drug Zepzelca. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg vials of the cancer drug ZEPZELCA, with a ceiling value of $9,025.76 and an ultimate completion date of September 12, 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $9,025.76 Firm Fixed Price Delivery Order is for the supply of Zepzelca 4 mg vials, a prescription medication. The award is not associated with a set-aside program and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ZEPZELCA 4 MG VIALS. The fixed-price, firm-fixed-price contract has a ceiling value of $18,675.40 and an ultimate completion date of January 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $9,025.76 to supply ZEPZELCA 4 MG VIALS. The order has a completion date of February 2, 2024 and was awarded on January 11, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to support DLA Troop Support Medical programs. No set-aside designation was...